Briefing

Britain’s cannabis revolution: understanding the impact

Please note this event has sold out. You can join our waiting list and be the first to know if any additional tickets are made available for the event.

All over the world, legal cannabis is big business – and Britain is no exception. Investors, patients and politicians are all caught up in the so called ‘green rush’ – but what is the truth behind the hype? Join The Spectator to find out.

In association with DAC Beachcroft and supported by Prohibition Partners

Speakers

Tonia Antoniazzi

Tonia Antoniazzi

All-Party Parliamentary Group on Medical Cannabis under Prescription

Professor Mike Barnes

Professor Mike Barnes

Neurologist; Hon Professor of Neurological Rehabilitation, Newcastle University; and chief medical officer, European Cannabis Holdings

Gregg Battersby

Gregg Battersby

Managing Director, Europe for Althea Group Holdings (ASX: AGH)

Crispin Blunt

Crispin Blunt

Co-chair, All Party Parliamentary Group on Drug Policy Reform

Hannah Deacon

Hannah Deacon

Campaigner, End Our Pain & Alfie Dingley’s mother

Jonathan Deverill

Jonathan Deverill

Partner, Corporate, DAC Beachcroft

Melissa Sturgess

Melissa Sturgess

CEO, Ananda Developments

Marcus Stuttard

Marcus Stuttard

Head of UK Primary Markets, London Stock Exchange

Fraser Nelson

Fraser Nelson

Editor, The Spectator

Venue

Ham Yard Hotel, London, W1D 7DT